Cerecor Inc.

(CERC) Trade

By |

Profile

Cerecor Inc is a clinical stage biopharmaceutical company operating in the US. It is engaged in developing drug candidates for patients with neurological and psychiatric disorders. The company holds a portfolio of novel clinical and preclinical compounds for a variety of indications including CERC-301, CERC-501 which is for substance use disorders and adjunctive treatment of MDD and CERC-406 which is preclinical candidate of compounds that inhibit catechol-O-methyltransferase (COMT) within the brain. The company owns a right to COMTi platform which is an enzyme that is critical for the inactivation and metabolism of dopamine.

Contact Information

Website: www.cerecor.com
Email: john.woolford@westwicke.com
Main Phone: +1 410 522-8707
Address: 400 East Pratt Street
Address 2: Suite 606
State: MD
City / Town: Baltimore
Country: USA
Postal Code: 21202

Issuer Information

Exchange: NSC
CEO: Peter S. Greenleaf
Employees: 38
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 3.28 $ 0.0103 (0.31%)
Last Price 3.28 Change $ 0.0103 Change % 0.31 Tick N/A
Bid 3.28 Bid Size 200.00 Ask 3.31 Ask Size 300.00
Open 3.29 High 3.39 Low 3.26 Prev Close 3.27
Last Trade Volume 25,506 52 Wk Hi 5.74 52 Wk Low 2.00
Market Cap 133.9 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 40,806,053.00 EPS (TTM) -1.25 PE Ratio N/A Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 2 3
Number of Buys 2 3
Number of Sells 0 0
Net Activity 412500 412785
Last 10 Buys Shares
Peter Lichtlen 1,000
Robert C. Moscato 1,000
Last 10 Sell Shares
N/A 0
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 5.5 5.5 5.5 5.5
Low Target Price Estimate 5.5 5.5 5.5 5.5
Mean Target Price Estimate 5.5 5.5 5.5 5.5
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 05/17/18 05/17/18 05/17/18 05/17/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 0 0 0 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 0 0 3